Actively Recruiting
Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
Led by University of Miami · Updated on 2025-09-03
150
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.
CONDITIONS
Official Title
Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years of age or older who can give consent
- Scheduled to undergo percutaneous nephrolithotomy (PCNL) at Uhealth Tower or Jackson Memorial Hospitals
- Not currently immunosuppressed with a white blood count (WBC) of 2 or higher and not on immunosuppressive medications
You will not qualify if you...
- Unable to consent or younger than 18 years
- Currently immunosuppressed with a white blood count (WBC) less than 2 or taking immunosuppressive medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Miami
Miami, Florida, United States, 33136
Actively Recruiting
Research Team
H
Hemendra N Shah
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here